Montage Articles
By M. Safwan Badr, MD, MBA Central sleep apnea (CSA) is a form of sleep-disordered breathing in which decreased or absent flow is coupled with an absence or reduction in effort. CSA is not a single disorder but represents central breathing instability in [...]
By Shalini Paruthi, MD; Umesh Goswami, MD; Jennifer So, MD; Pahnwat Taweesedt, MD; Navin Verma, MD; and Steven Holfinger, MD, MS, on behalf of the AASM Emerging Technology Committee Technological breakthroughs in fabrication have improved tolerability and adherence to mandibular advancement devices (MADs), [...]
By the Coding and Reimbursement Advisory Committee Cognitive behavioral therapy for insomnia (CBT-I) is the first-line, evidence-based treatment for chronic insomnia. Unlike pharmacological approaches, CBT-I focuses on identifying and modifying the thoughts and behaviors that perpetuate sleep difficulties. It has been shown to [...]
By Reena Mehra, MD, MS, FAASM, and Dennis Auckley, MD, FAASM The first American Academy of Sleep Medicine clinical practice guideline addressing the topic of inpatient sleep medicine examines obstructive sleep apnea (OSA) in medically hospitalized adults. To date, the existing clinical paradigm [...]
By Kevin Postol, DDS, president of the American Academy of Dental Sleep Medicine Advances in technology have impacted awareness, diagnosis and treatment for obstructive sleep apnea (OSA). Wearables now provide patients with insights into whether they may be at risk for sleep apnea. [...]
By Kate Robards, senior writer Physicians spend a substantial amount of time on documentation, often more than they spend with their patients. An article published in JAMA Network Open found that primary care visits average about 30 minutes, while physicians typically spend 36 [...]
By the Coding and Reimbursement Advisory Committee Remote monitoring services refer to the use of digital technologies to collect, transmit and analyze health data from patients outside of traditional health care settings, such as in their homes. These services enable health care professionals [...]
By Kate Robards, senior writer In December 2023, the U.S. Food and Drug Administration approved tirzepatide (Zepbound) as the first medication indicated for treating moderate-to-severe obstructive sleep apnea (OSA) in adults who also have obesity. This landmark approval, backed by data from the [...]
Each issue of Montage highlights timely ideas, clinical insights, and member voices that reflect the evolving field of sleep medicine. In this issue, Dr. Judette Louis brings sleep into the maternal health conversation, and patient advocate Matt Horsnell shares a viewpoint on holistic [...]
Hypoglossal nerve stimulation for treating obstructive sleep apnea (OSA) became a viable clinical option following its FDA approval in the United States in 2014. Sleep medicine providers will typically bill codes 95970, 95976 and 95977, which are used for the programming and analysis [...]